News
Class I Medical Device Recall: HeartSine Samaritan Public Access Defibrillator 300/300P
November 19, 2012 12:00 am | by U.S. Food & Drug Administration | CommentsReason for Recall: The firm issued a letter to customers on Sept. 11, 2012 describing the problem and provided instructions for correction. Certain Samaritan® 300/300P PAD devices have been found to intermittently turn on and off, which may eventually...
NFL tackles switch to electronic health records with eClinicalWorks
November 19, 2012 12:00 am | by Mass High Tech: The Journal of New England Technology | CommentsThe National Football League (NFL) is using Westborough-based eClinicalWorks to facilitate its move from paper to electronic medical records, the company said in a statement.
New Family of OCT Products and New Eye Care Data Management Software Introduced at Annual Meeting of Ophthalmology
November 16, 2012 10:41 pm | by The Associated Press | CommentsCHICAGO & DUBLIN, Calif. & JENA, Germany--(BUSINESS WIRE)--Nov 16, 2012--Medical technology manufacturer Carl Zeiss Meditec introduced a new family of OCT products spanning the full spectrum of multi-modality imaging for retinal disease and glaucoma at the 2012 Joint Meeting of the...
Angiotech partner Cook Medical receives FDA approval for its Zilver PTX Paclitaxel-eluting peripheral stent
November 16, 2012 5:32 pm | by The Associated Press | CommentsAngiotech Pharmaceuticals, Inc. ("Angiotech") announced that its partner Cook Medical, Inc. ("Cook") received approval on November 15, 2012 from the U.S. Food and Drug Administration ("FDA") to market and sell the proprietary Zilver@ PTX@ drug-eluting peripheral stent, adding the United States to the list of over 50 markets, including the European Union and Japan, where Zilver PTX is approved for sale.
First U.S. Patient Treated in Medtronic Clinical Trial Evaluating CoreValve® System in Intermediate-Risk Patients
November 16, 2012 2:06 pm | by The Associated Press | CommentsMINNEAPOLIS - November 16, 2012 - Medtronic, Inc. (NYSE: MDT) today announced the first treatment of a U.S. patient in its global, multicenter, randomized clinical trial comparing the Medtronic CoreValve® System with surgical aortic valve replacement in patients with severe...
HeartWare Presentation At The 24th Annual Piper Jaffray Healthcare Conference To Be Webcast
November 16, 2012 1:48 pm | by Bio-Medicine.Org | CommentsFRAMINGHAM, Mass. and SYDNEY, Nov. 16, 2012 /- HeartWare International, Inc. (NASDAQ: HTWR - ASX: HIN), a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, today announced that CEO Doug Godshall is scheduled to present at the 24 th Annual Piper Jaffray Healthcare Conference at 8:30...
Spiracur wins 2 Medicare reimbursement codes for its wound care systems
November 16, 2012 1:46 pm | by Mass Device | CommentsSunnyvale, Calif.-based Spiracur lands a pair of healthcare common procedure coding system codes for reimbursement of its negative pressure wound therapy system. Homepage TeasesNews Well Medtech maker Spiracur was awarded 2 new Medicare reimbursement codes for its negative-pressure SNaP wound care system, a device which aims to help physicians heal wounds more rapidly for their patients. The HCPCS codes G0456 and G0457, which were issued from the Centers for Medicare & Medicaid Services, are for clinical services using a mechanically-powered device, providing an effective, off-the-shelf solution for negative pressure wound therapy, Spiracur said. News Well, HCPCS Codes, Medicare, Reimbursement, Wound Therapyread more
Hill-Rom, Stryker settle patent beef
November 16, 2012 1:32 pm | by Mass Device | CommentsHill-Rom and Stryker settle a patent infringement lawsuit over powered hospital bed wheels. Legal News, News Well, Hospital Care, Patent Infringementread more
Ingen Receives Favorable Analyst Report
November 16, 2012 1:21 pm | by The Associated Press | CommentsIngen Technologies, Inc. (PINKSHEETS: IGNT), an emerging medical device manufacturer with patented proprietary technology for the growing $4 billion Respiratory Market, is pleased to announce that it will release an Analyst Research Report on December 3, 2012. The in-depth report forecasts...
OmniGuide® Named to Deloitte’s 2012 Technology Fast 500™
November 16, 2012 11:09 am | by The Associated Press | CommentsBOSTON--(BUSINESS WIRE)--Nov 16, 2012--OmniGuide, Inc. a leading developer of advanced microsurgical energy devices announced today that it was ranked in the Deloitte 2012 Technology Fast 500™. The list, which ranks the fastest growing technology companies by percentage revenue growth from...
CoActiv Debuts Major Enhancements to EXAM-PACS at RSNA 2012
November 16, 2012 11:08 am | by The Associated Press | CommentsRIDGEFIELD, Conn.--(BUSINESS WIRE)--Nov 16, 2012--CoActiv (Booth # 7303), the digital medical imaging innovator, announces a broad range of introductions and enhancements to its EXAM-PACS ®, EXAM-RIS ® and cloud-based digital archiving family at the RSNA 2012 conference in November. At RSNA,...
Micronit, Fluigent, and Zurich Instruments join forces creating the world's first commercial platform for micro electrical impedance spectroscopy.
November 16, 2012 10:36 am | by I-Micronews | CommentsThe three companies are combining their state-of-the-art products and services in order to provide a novel combination to academic and industrial scientists intending to invest in the emerging biotechnology field of high-speed electrical sample characterization.
CDA and Häcker Automation announce cooperation
November 16, 2012 10:36 am | by I-Micronews | CommentsCDA GmbH, a recognized specialist for complex multi-μ-functional solutions on plastics, and Häcker Automation, a leading engineering manufacturer of universal standard platforms for 3D micro-packaging and interconnection, announce their cooperation in the fields of lab-on-a-chip and embedded diagnostic systems.
New injectable gels toughen up after entering the body
November 16, 2012 10:26 am | by Massachusetts Institute of Technology | CommentsGels that can be injected into the body, carrying drugs or cells that regenerate damaged tissue, hold promise for treating many types of disease, including cancer. However, these injectable gels don't always maintain their solid structure once inside the body.
Gore defends PFO closure devices in the aftermath of the St. Jude RESPECT trial
November 16, 2012 10:15 am | by Mass Device | CommentsW.L. Gore & Associates defends patent foramen ovale closure devices after St. Jude's RESPECT study, which failed to meet clinical endpoints, demonstrates that proper patient inclusion criteria are "imperative" to successful treatment. News Well, Clinical Trials, Cardiac Implantsread more
